MRI引导高强度聚焦超声治疗运动障碍:精准影像靶向病理脑回路——AJR关键解剖专题系列
本文综述MRI引导高强度聚焦超声(MRgHIFU)治疗药物难治性运动障碍的靶向策略。传统间接靶点因解剖与功能变异导致疗效有限或不良反应;扩散张量成像纤维束示踪与白质抑制序列使患者特异性直接靶向病理脑回路成为可能,齿状核-红核-丘脑束靶向在特发性震颤中显示高震颤抑制且不良反应少,苍白球-丘脑束靶向在帕金森病中同样展现前景。
要点
- MRgHIFU为无切口治疗,无法像开放手术那样用微电极记录实时修正间接靶点。
- 扩散张量成像纤维束示踪与白质抑制序列可实现患者特异性直接靶向病理白质束。
- 特发性震颤靶向齿状核-红核-丘脑束显示高震颤抑制且不良反应少,帕金森病靶向苍白球-丘脑束具前景。
核心结论
- MRgHIFU直接靶向疾病特异性白质束的患者特异性策略可提高精准度、疗效与安全性,人工智能驱动方法有望进一步增强靶向并拓宽其在个体化运动障碍治疗中的作用。
研究设计与样本
- 综述类文章,属于AJR关键解剖专题系列,围绕MRgHIFU治疗运动障碍的靶向策略进行论述。
关键影像表现/征象
- 间接靶向皮质下灰质结构的临床疗效日益被认为源于沿白质通路分布的回路水平神经调控。
- 传统MRgHIFU采用间接靶点,因解剖或功能变异导致疗效有限或出现不良反应。
诊断标准与关键数值
- 特发性震颤中MRgHIFU靶向齿状核-红核-丘脑束已显示高震颤抑制且不良反应少。
- 帕金森病中靶向苍白球-丘脑束同样已成为有前景的干预方式。
临床应用与阅片要点
- 传统MRgHIFU使用间接靶点,因解剖或功能变异可致疗效有限或不良反应。
- 扩散张量成像纤维束示踪与白质抑制序列(如快速灰质获取T1反转恢复序列)可用于患者特异性靶向病理脑回路。
- 作者认为基于白质束的靶向方法可利用患者特异性靶向提高精准度、疗效与安全性。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
MRI-guided high-intensity focused ultrasound (MRgHIFU) has emerged as an alternative to other neuromodulatory interventions for patients with medically refractory movement disorders, including open surgery, radiosurgery, and deep brain stimulation. Microelectrode recordings permit refinement of indirect targets during open procedures for movement disorders. However, their use is not possible during incisionless procedures, including MRgHIFU. Traditional MRgHIFU using indirect targets yields limited efficacy or adverse effects from anatomic or functional variability. Furthermore, the clinical efficacy associated with indirect targeting of subcortical gray matter structures is increasingly recognized as resulting from circuitwide neuromodulation distributed along white matter pathways. Additionally, diffusion tensor imaging tractography and white matter-nulled sequences (e.g., fast gray matter acquisition T1 inversion recovery) now enable patient-specific targeting of pathologic brain circuits. These developments are prompting growing interest in MRgHIFU for direct targeting of disease-specific white matter tracts. In essential tremor, dentatorubrothalamic tract targeting by MRgHIFU has shown high tremor suppression with few adverse effects; in Parkinson disease, pallidothalamic tract targeting has likewise emerged as a promising intervention. These tract-based approaches can leverage patient-specific targeting to improve precision, efficacy, and safety. Future developments, including artificial intelligence-driven approaches, are expected to enhance MRgHIFU targeting and broaden its role in personalized movement disorder therapy.
引用
- Asturias A, Saez-Calveras N, Yu J, et al. MRI-Guided High-Intensity Focused Ultrasound in Movement Disorders: Targeting Pathologic Brain Circuits With Precision Imaging, From the AJR Special Series on Critical Anatomy. AJR Am J Roentgenol. 2026. PMID: 41983872. doi:10.2214/AJR.25.34168
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。